N'-DesMethyl AzithroMycin
|
|
|
- CAS-Nr.
- 172617-84-4
- Englisch Name:
- N'-DesMethyl AzithroMycin
- Synonyma:
- N-Demethylazithromycin;CP-64434;Azithromycin-4;CP-64434 hydrate;Azithromycin EP Imp I;N'-Desmethyl azithromycin;3'-N-Demethylazithromycin;3′-N-Desmethylazithromycin;Na€-Desmethyl Azithromycin;3′-N-Demethyl Azithromycin
- CBNumber:
- CB52544020
- Summenformel:
- C37H70N2O12
- Molgewicht:
- 734.96
- MOL-Datei:
- 172617-84-4.mol
|
N'-DesMethyl AzithroMycin Eigenschaften
- Siedepunkt:
- 821.4±65.0 °C(Predicted)
- Dichte
- 1.18±0.1 g/cm3(Predicted)
- storage temp.
- room temp
- L?slichkeit
- DMSO: ≥10mg/mL
- pka
- 13.28±0.70(Predicted)
- Aggregatzustand
- powder
- Farbe
- white to off-white
- Stabilit?t:
- Hygroscopic
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
| H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
| H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
|
|
| Sicherheit |
| P261 |
Einatmen von Staub vermeiden. |
| P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
N'-DesMethyl AzithroMycin Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White Solid
N'-DesMethyl AzithroMycin Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
N'-DesMethyl AzithroMycin Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 99)Lieferanten
172617-84-4()Verwandte Suche:
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-Methyl-3-O-Methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptaMethyl-11-[[3,4,6-trideoxy-3-(MethylaMino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one
- CP-64434
- N-DesMethyl AzithroMycin (IMpurity I)
- 3′-N-Desmethylazithromycin
- CP-64434 hydrate
- N′-Desmethylazithromycin hydrate
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-
trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-
dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-(((2R,3R,4S,6R)-
3-hydroxy-6-methyl-4-(methylamino)tetrahydro-2H-pyran-2-
yl)oxy)-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-
15-one
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)‐2‐ethyl‐3,4,10‐trihydroxy‐13‐{(2R,4R,5S,6S)‐5‐hydroxy‐4‐methoxy‐4,6‐dimethyl-tetrahydropyran‐2‐yloxy}‐11‐{(2S,3R,4S,6R)‐3‐hydroxy‐6‐methyl‐4‐methylamino-tetrahydropyran‐2‐yloxy}‐3,5,6,8,10,12,14‐heptamethyl‐1‐oxa‐6‐azacyclopentadecan‐15‐one
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(methylamino)
- Azithromycin Impurit Ⅳ：( Impurit I)N'-Desmethyl Azithromycin
- Azithromycin EP Impurity I(USP)
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-11-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10- trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6- dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-(((2R,3R,4S,6R)- 3-hydroxy-6-methyl-4-(methylamino)tetrahydro-2H-pyran-2- yl)oxy)-3,5,6,8,10,12,14-heptame
- Azithromycin EP Imp I
- Azithromycin-4
- Azithromycin EP Impurity I/(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-(((2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-3
- Azithromycin Impurity 9（Azithromycin EP Impurity I）
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-(((2R,3R,4S,6R)-3-hydroxy-6-methyl-4(methylamino)tetrahydro -2H-pyran-2-yl)oxy)-3,5,6,8,10,12,14-heptamethyl
- Azithromycin EP Impurity I (N-Desmethyl Azithromycin)
- Na€-Desmethyl Azithromycin
- Azithromycin Impurity I(N-Desmethyl Azithromycin)
- Azithromycin Impurity I(BP)
- N-Demethylazithromycin (USP)
- 3′-N-Demethyl Azithromycin
- 1-Oxa-6-azacyclopentadecan-15-one, 13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(methylamino)-β-D-xylo-hexopyranosyl]oxy]-, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-
- USP N-Demethylazithromycin
- Azithromycin EP Impurity I/ N-Demethylazithromycin (3′-N-Demethyl Azithromycin)
- Azithromycin EP impurity IQ: What is
Azithromycin EP impurity I Q: What is the CAS Number of
Azithromycin EP impurity I Q: What is the storage condition of
Azithromycin EP impurity I Q: What are the applications of
Azithromycin EP impurity I
- N-Demethylazithromycin
- Azithromycin BP Impurity-I
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-(((3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-3,5,6,8,10,12,14-heptamethyl-1-
- N'-Desmethyl azithromycin
- Azithromycin impurity I, EvoPure
- N’-Desmethyl Azithromycin/CP-64434 hydrate
- 3'-N-Demethylazithromycin
- 172617-84-4
- Chiral Reagents
- Intermediates & Fine Chemicals
- Metabolites & Impurities
- Pharmaceuticals
